Optimization of a transmural care pathway for allergen immunotherapy to primary care by an integrated personal eHealth environment
Allergy
.
2021 Jul;76(7):2259-2261.
doi: 10.1111/all.14753.
Epub 2021 Feb 27.
Authors
Johanna P M van der Valk
1
,
Jasper H Kappen
1
2
,
Sanne Ruikes-Mertens
3
,
Maurits S van Maaren
4
,
Patrick J E Bindels
5
,
Roy Gerth van Wijk
4
,
G J Braunstahl
1
6
Affiliations
1
Department of Pulmonary Medicine, Franciscus Gasthuis & Vlietland, Rotterdam, The Netherlands.
2
Allergy and Clinical Immunology, Immunomodulation and Tolerance Group, Imperial College London, London, UK.
3
Department of Internal Medicine, Allergology, Maasstad Hospital, Rotterdam, The Netherlands.
4
Department of Internal Medicine, Allergology, Erasmus Medical Center, Rotterdam, The Netherlands.
5
Department of General Practice, Erasmus Medical Center, Rotterdam, The Netherlands.
6
Department of Pulmonary Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.
PMID:
33502783
DOI:
10.1111/all.14753
No abstract available
Keywords:
allergen immunotherapy; eHealth; feasibility; primary care; secondary care.
Publication types
Research Support, Non-U.S. Gov't
MeSH terms
Desensitization, Immunologic
Humans
Primary Health Care
Telemedicine*